Bulletin
Investor Alert

New York Markets Open in:

Hoth Therapeutics Inc.

NAS: HOTH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 7, 2020, 7:59 p.m.

/zigman2/quotes/202955754/composite

$

2.41

Change

-0.13 -5.12%

Volume

Volume 4,018

Quotes are delayed by 20 min

/zigman2/quotes/202955754/composite

Previous close

$ 2.44

$ 2.54

Change

+0.10 +4.10%

Day low

Day high

$2.33

$2.57

Open

52 week low

52 week high

$2.31

$7.87

Open

Insider Actions for Hoth Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/26/2020 AIkido Pharma, Inc.
400,000   Disposition at $1.25 per share. 500,000
04/15/2020 Graig Springer
Director
3,333   Award at $0 per share. 0
04/15/2020 Wayne D. Linsley
Director
3,333   Award at $0 per share. 0
11/08/2019 AIkido Pharma, Inc.
9,226   0
10/28/2019 AIkido Pharma, Inc.
90,258   0
10/28/2019 Robbie Knie
CEO and President; Director
85   0
10/28/2019 Anthony C. Hayes
Director
301   0
02/28/2019 AIkido Pharma, Inc.
35,714   Acquisition at $5.59 per share. 199,641
02/20/2019 Matthew D. Eitner
15,000   Derivative/Non-derivative trans. at $0 per share. 0
02/20/2019 Kevin Jess Poor
750,000   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2017 AIkido Pharma, Inc.
1,700,000   Acquisition at $675,000 per share. 1,147,500,000,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
2 Purchases
1 Sales
6,666
400,000
Last 6 months
2 Purchases
1 Sales
6,666
400,000
Last 12 months
4 Purchases
3 Sales
7,052
499,484

Officers and Executives

Mr. Robbie Knie
Chairman, President & Chief Executive Officer
Ms. Jane H. Behrmann
Secretary & Vice President-Operations
Mr. David S. Briones
Chief Financial Officer
Mr. Kenneth L. Rice
Director
Mr. Wayne D. Linsley
Independent Director
Mr. Graig Springer
Independent Director
Mr. Vadim Mats
Independent Director
Mr. David B. Sarnoff
Independent Director
Link to MarketWatch's Slice.